MedPath

University Hospital Erlangen

University Hospital Erlangen logo
🇩🇪Germany
Ownership
Private
Established
1815-01-01
Employees
5K
Market Cap
-
Website
http://www.uk-erlangen.de

Clinical Trials

27

Active:1
Completed:17

Trial Phases

4 Phases

Phase 1:3
Phase 2:5
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials

Phase 2
5 (35.7%)
Not Applicable
4 (28.6%)
Phase 1
3 (21.4%)
Phase 3
2 (14.3%)

Diagnostic Imaging of Vascular Malformations Using MSOT and ULM

Not yet recruiting
Conditions
Vascular Malformation
Arteriovenous Malformation
Lymphatic Malformation
Venous Malformations
First Posted Date
2025-05-29
Last Posted Date
2025-06-22
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
15
Registration Number
NCT06994260
Locations
🇩🇪

University Hospital Erlangen, Department of Vascular Surgery, Erlangen, Bavaria, Germany

MSOT_PI Analysis of Revascularization Procedure Using Optoacoustic Imaging

Completed
Conditions
PAD
Vascular Diseases
First Posted Date
2025-05-11
Last Posted Date
2025-05-15
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
40
Registration Number
NCT06966297
Locations
🇩🇪

University Hospital Erlangen, Erlangen, Bavaria, Germany

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

Recruiting
Conditions
Polycystic Ovarian Syndrome (PCOS)
First Posted Date
2024-10-15
Last Posted Date
2024-10-15
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
380
Registration Number
NCT06642831
Locations
🇩🇪

Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany, Erlangen, Germany

Virtual Reality in the Rehabilitation in Patients With Lower Limb Amputation.

Not Applicable
Recruiting
Conditions
Lower Limb
Lower Extremity
Rehabilitation
Virtual Reality
Amputation
Activities of Daily Living
First Posted Date
2023-03-17
Last Posted Date
2023-03-17
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
20
Registration Number
NCT05773560
Locations
🇩🇪

University of Erlangen-Nuremberg (FAU), Department of Vascular Surgery, Erlangen, Bavaria, Germany

Investigation of the Learning Effect in the Measurement of Circulation in Calf Muscle Using MSOT

Recruiting
Conditions
Structural Similarity Index Measure
Image Interpretation, Computer-Assisted
Learning Curve
Multispectral Optoacoustic Tomography
First Posted Date
2023-03-17
Last Posted Date
2023-03-17
Lead Sponsor
University Hospital Erlangen
Target Recruit Count
20
Registration Number
NCT05773547
Locations
🇩🇪

University of Erlangen-Nuremberg (FAU), Department of Vascular Surgery, Erlangen, Bavaria, Germany

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

Failed Long COVID Drug Trial Reveals Critical Study Design Flaws as New Company Plans Restart

Berlin Cures' Phase 2 trial of BC 007 (rovunaptabin) for long COVID failed in November 2024 due to poor patient selection and inadequate outcome measures, despite some participants experiencing dramatic symptom improvements.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.